SITraN is one of the world leading centres for research into Motor Neurone Disease, Alzheimer’s and Parkinson’s Disease.
From basic neuroscience research to novel therapies and clinical trials -our aim is to improve the lives of patients with neurodegenerative disorders and their families worldwide.
Promising MND drug helps slow disease progression and benefits patients physically
World Parkinson's Day - UK Parkinson’s Clinical Study Group
Innovative gene therapy programme paves the way for new treatments for neurodegenerative diseases
Frequent strenuous exercise increases the chance of developing MND in genetically at risk individuals
New gene therapy innovation centre to advance scientific discoveries into life-changing treatments
Sheffield scientists awarded £1.2 million to design Parkinson’s drug
New study suggests genetic testing could be appropriate for all motor neuron disease (MND) patients whether or not they have a family history of the disease
SITraN: Ten Years of Impact
New partnership to take potential treatment for motor neurone disease (MND) into clinical trials
Encouraging early study for investigational drug in people with motor neurone disease
Media service Fundraising